NCT05191745View on ClinicalTrials.gov

Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

April 28, 2023

Study Completion Date

June 1, 2024

Conditions
Coronary Artery Bypass Graft Surgery
Interventions
DRUG

Parasternal blocks

Parasternal block with Bupivacaine 0.25% + Epinephrine 1:200,000 x 60cc + Dexamethasone 5mg and Dexmedetomidine 50mcg

DRUG

Standard of care

All standard management of postoperative pain, as per local protocols

Trial Locations (1)

H3T1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Jewish General Hospital

OTHER